2021
DOI: 10.1007/s10856-021-06520-y
|View full text |Cite
|
Sign up to set email alerts
|

3D bioprinting of cardiac tissue: current challenges and perspectives

Abstract: Demand for donor hearts has increased globally due to cardiovascular diseases. Recently, three-dimensional (3D) bioprinting technology has been aimed at creating clinically viable cardiac constructs for the management of myocardial infarction (MI) and associated complications. Advances in 3D bioprinting show promise in aiding cardiac tissue repair following injury/infarction and offer an alternative to organ transplantation. This article summarizes the basic principles of 3D bioprinting and recent attempts at … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
28
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(28 citation statements)
references
References 68 publications
0
28
0
Order By: Relevance
“…Bioprinting is the future of 3D printing technology in medical applications, with significant progress made in printing cardiovascular constructs, cardiovascular regeneration and pharmacology over the last decades [ 94 , 95 , 96 , 97 , 98 , 99 ]. Figure 15 outlines the scheme of 3D bioprinting technology in the cardiovascular system.…”
Section: Limitations Barriers and Future Directionsmentioning
confidence: 99%
“…Bioprinting is the future of 3D printing technology in medical applications, with significant progress made in printing cardiovascular constructs, cardiovascular regeneration and pharmacology over the last decades [ 94 , 95 , 96 , 97 , 98 , 99 ]. Figure 15 outlines the scheme of 3D bioprinting technology in the cardiovascular system.…”
Section: Limitations Barriers and Future Directionsmentioning
confidence: 99%
“…In addition, if autologous cells are used, the immune response is less likely to be stimulated. [ 18 ] Despite the advantages of 3D bioprinting, it faces several challenges, such as lack of availability of polymers, poor adhesion, viability, and short life of bioinks. [ 19 ] However, the use of nanotechnology in the 3D printing of heart tissues can play a momentous role in this regard.…”
Section: Current Status Of Cardiac Tissue Engineeringmentioning
confidence: 99%
“…The extrusion-based 3D printing is a facile, less complex and affordable 3D printing approach (Mandrycky et al, 2016;Kato et al, 2021). The cell deposition density usually ranges from 10 8 -10 9 cells per mL which is crucial for cardiac tissue engineering (Pati et al, 2014).…”
Section: Extrusion-based 3d Bioprintingmentioning
confidence: 99%